Shares of Hyperfine (NASDAQ:HYPR) gained 4% in premarket trading on Tuesday after the company announced that it is expected to be added to both the Russell 3000 Index and the Russell 2000 Index.
Russell inclusion set to take effect after June reconstitution
The medical technology company said its inclusion is expected to occur as part of the June 2026 Russell index reconstitution process, based on a preliminary list published by FTSE Russell on May 22, 2026.
The changes are scheduled to become effective following the close of U.S. trading on June 26, 2026.
Russell indexes track largest U.S. listed companies
The annual Russell U.S. index reconstitution ranks up to 4,000 of the largest publicly traded American companies based on total market capitalization as of April 30.
Companies included in the Russell 3000 Index are automatically assigned to either the large-cap Russell 1000 Index or the small-cap Russell 2000 Index.
Russell indexes are widely followed by institutional investors and asset managers, serving as benchmarks for both index-tracking funds and actively managed investment strategies.
According to FTSE Russell data, approximately $12.2 trillion in assets were benchmarked against Russell U.S. indexes as of the end of June 2025.
Hyperfine continues expansion of portable MRI platform
Hyperfine develops the Swoop portable MRI system, described as the first FDA-cleared AI-powered portable MRI platform for brain imaging.
The system is designed to enable MRI imaging across multiple points of care and clinical settings.
CEO says inclusion reflects commercial progress
Maria Sainz, President and Chief Executive Officer of Hyperfine, said the company’s anticipated Russell index inclusion highlights ongoing execution of its commercial growth strategy and rising awareness of its portable MRI technology.